Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients

ClinicalTrials.gov ID: NCT00002415

Public ClinicalTrials.gov record NCT00002415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Antiviral Activity of the Addition of PMPA Prodrug to Combination Antiretroviral Regimens in Treatment-Experienced HIV-Infected Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if it is safe and effective to add PMPA Prodrug (a new anti-HIV drug) to an anti-HIV drug combination taken by patients who have taken anti-HIV drugs in the past. Genetic response will be studied.

Study identification

NCT ID
NCT00002415
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
175 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Univ of Alabama at Birmingham / 1917 Rsch Cln Birmingham Alabama 35294
McDowell Clinic Phoenix Arizona 85016
East Bay AIDS Ctr Berkeley California 94705
Tower Infectious Disease Med Ctr Los Angeles California 90048
UCSD Treatment Ctr San Diego California 92103
San Francisco Veterans Adm Med Cntr San Francisco California 94121
Harbor UCLA Med Ctr Torrance California 90502
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Hillsborough County Health Dept Special Care Ctr Tampa Florida 33605
AIDS Research Consortium of Atlanta Inc Atlanta Georgia 30308
Grady Mem Hosp Atlanta Georgia 30308
Private Practice / Thacker and Thompson Atlanta Georgia 30324
Northstar Med Clinic Chicago Illinois 60657
CRI New England Brookline Massachusetts 02445
Univ of Minnesota Minneapolis Minnesota 55455
Beth Israel Med Ctr New York New York 10003
Cornell Clinical Trials Unit - Chelsea Clinic New York New York 10011
Univ Hosps of Cleveland Cleveland Ohio 44106
The Research and Education Group Portland Oregon 97210
Hershey Med Ctr Hershey Pennsylvania 17033
Anderson Clinical Research Pittsburgh Pennsylvania 15213
Roger Williams Med Ctr Providence Rhode Island 02908
Amelia Ct Clinic Dallas Texas 75235
Thomas Street Clinic Houston Texas 77009

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002415 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →